Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ProtaGene Appoints New Scientific and Commercial Leadership to Support Evolving Needs of Biologic and Cell & Gene Therapy Innovators
ProtaGene, a leading global contract research organization focused on advanced analytics in biologics and cell […]
MyndVR Partners with AgeWell New York for First Health Care Coverage Plan
MyndVR, the award-winning provider of VR-based, digital therapeutic experiences designed for the aging population, has […]
MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson's Disease
MedRhythms announced the successful completion of a multi-site feasibility study of MR-005, its investigational asset […]
Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome
Ionis Pharmaceuticals today announced that the United States Food and Drug Administration (FDA) has granted […]
Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear
Sensorion, a pioneering clinical-stage biotechnology company that specializes in the development of novel therapies to […]
Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors
Qurient, a clinical-stage biotech company based in Korea, has announced that the first patient has […]
Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors
Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure […]
Bruno Ultra Barcelos is appointed Managing Director of Ethypharm UK
The Ethypharm Group, a European pharmaceutical company focused on the Central Nervous System and Hospital […]
Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform, Omni Pro 12
Axion BioSystems today announces the addition of the Omni Pro 12 to the Omni live-cell […]
CHOP Experts Share Cutting-Edge Innovations at Arab Health Exhibition
Showcasing its longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children’s […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more